Jentadueto XR 2.5 mg/1 (Linagliptin and Metformin Hydrochloride TABLET, FILM COATED, EXTENDED RELEASE) 2.5 mg/1

Jentadueto XR 2.5 mg/1 combines linagliptin and metformin hydrochloride for managing type 2 diabetes. This extended-release tablet supports blood sugar control as part of a comprehensive treatment plan.

Strength

2.5 mg/1

Pack Size

60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0597-0270-73)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Jentadueto XR 2.5 mg/1 is primarily used for managing type 2 diabetes in adults. It works by improving blood sugar levels, often when diet and exercise alone are not sufficient. This medication is typically prescribed to help control high blood sugar, a common concern for those with type 2 diabetes. It is not intended for treating type 1 diabetes or diabetic ketoacidosis.

Side Effects

Common effects of Jentadueto XR 2.5 mg/1 may include gastrointestinal discomfort, such as diarrhea or nausea. Some users might experience headache or dizziness. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

Jentadueto XR 2.5 mg/1 should be handled with care, especially for those with kidney issues or a history of lactic acidosis. It is important to follow the prescribed dosage and administration instructions. Regular monitoring of blood sugar levels is recommended while using this medication.

Avoid Interactions

Jentadueto XR 2.5 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Jentadueto XR 2.5 mg/1 is used to manage type 2 diabetes by improving blood sugar control.

Jentadueto XR 2.5 mg/1 is taken orally, typically once daily with a meal, as directed by a healthcare provider.

Common side effects may include gastrointestinal discomfort, headache, and dizziness.

Potential interactions exist with other diabetes drugs, diuretics, and some antibiotics; consult a healthcare provider.

Jentadueto XR 2.5 mg/1 is specifically for type 2 diabetes and not suitable for type 1 diabetes or diabetic ketoacidosis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.